Detection of Tyrosine Kinase Inhibitors-Induced COX-2 Expression in Bladder Cancer by Fluorocoxib A

Oncotarget - United States
doi 10.18632/oncotarget.27125
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Tyrosine Kinase Inhibitors in Lung Cancer

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer

Journal of the Siena Academy of Sciences
2012English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

SRC Tyrosine Kinase Activation by 4-Hydroxynonenal Upregulates P38, ERK/AP-1 Signaling and COX-2 Expression in YPEN-1 Cells

PLoS ONE
Multidisciplinary
2015English

EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions

Current Oncology
Oncology
2012English

EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions

Current Oncology
Oncology
2012English

Over-Expression of COX-2 mRNA in Colorectal Cancer

BMC Gastroenterology
MedicineGastroenterology
2014English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy